Skip to content

Small Molecule Discovery Center and Genentech partner in drug discovery

By UCSF School of Pharmacy Editorial Staff / Fri Feb 19, 2010

gears working together

© majedphoto.com

UCSF's Small Molecule Discovery Center (SMDC) announced on February 18, 2010 that it has signed its first major industry partnership agreement since the SMDC was founded in 2005. The agreement is with Genentech, Inc. to discover and develop drug candidates for neurodegenerative diseases. Genentech will provide funding and its research acumen in neuroscience and will collaborate with UCSF to identify small molecules. The SMDC is administered by the UCSF School of Pharmacy and directed by James Wells, PhD, chair of the School's Department of Pharmaceutical Chemistry.

Full story

UCSF enters drug discovery agreement with Genentech

More

UCSF, Genentech Strike $13 million deal

Tags

Topics:

drugs, neurodegenerative diseases, Genentech, neuroscience, Small Molecule Discovery Center (SMDC)

Category:

Sites:

School of Pharmacy, Department of Pharmaceutical Chemistry, PharmD Degree Program, QBC, CCB, Biophysics

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.